These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 795398)

  • 41. Improvements in the quality and consistency of production of dried BCG vaccine (Romanian substrain).
    Drăghici D; Balazs D; Piţur I
    Dev Biol Stand; 1986; 58 ( Pt A)():127-32. PubMed ID: 3596024
    [No Abstract]   [Full Text] [Related]  

  • 42. [Examination of protein MPB 70 properties in BCG substrains used for the production of Polish antituberculosis vaccines].
    Janaszek W; Wysokińska T; Aleksandrowicz J
    Med Dosw Mikrobiol; 1998; 50(1-2):47-54. PubMed ID: 9857613
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination.
    Young SL; Slobbe L; Wilson R; Buddle BM; de Lisle GW; Buchan GS
    Infect Immun; 2007 Jun; 75(6):2833-40. PubMed ID: 17371857
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mycobacterium avium subsp. paratuberculosis-specific mpt operon expressed in M. bovis BCG as vaccine candidate.
    Heinzmann J; Wilkens M; Dohmann K; Gerlach GF
    Vet Microbiol; 2008 Aug; 130(3-4):330-7. PubMed ID: 18343053
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An interlaboratory comparative assay of viability and heat stability control of different BCG vaccines on two solid culture media.
    Suire A; Gheorghiu M
    Dev Biol Stand; 1986; 58 ( Pt A)():155-62. PubMed ID: 3297861
    [No Abstract]   [Full Text] [Related]  

  • 46. Protective immunity against Mycobacterium bovis induced by vaccination with Rv3109c--a member of the esat-6 gene family.
    Hogarth PJ; Logan KE; Vordermeier HM; Singh M; Hewinson RG; Chambers MA
    Vaccine; 2005 Apr; 23(20):2557-64. PubMed ID: 15780437
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The efficacy and side reactions in humans immunized with Danish strain of dried BCG of Shanghai].
    Zhu G; Tao H; Huang Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Apr; 15(2):80-2. PubMed ID: 7923337
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Conclusions and recommendations arising out of a W.H.O. informal consultation on 'The choice of a BCG strain' for the production of freeze-dried vaccine. Bilthoven, 10 March 1976.
    J Biol Stand; 1977; 5(2):83-4. PubMed ID: 328508
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of freeze-drying on the colony morphology of various daughter strains of BCG.
    Gupta KC
    J Biol Stand; 1975; 3(4):349-52. PubMed ID: 1102547
    [No Abstract]   [Full Text] [Related]  

  • 50. The chemistry and biology of a hot water extract from delipidated Mycobacterium bovis, strain BCG.
    Yokosawa A
    Sci Rep Res Inst Tohoku Univ Med; 1978 Dec; 25(3-4):65-82. PubMed ID: 379996
    [No Abstract]   [Full Text] [Related]  

  • 51. Characterization and comparison of mycobacterial antigens by two-dimensional immunoelectrophoresis.
    Roberts DB; Wright GL; Affronti LF; Reich M
    Infect Immun; 1972 Oct; 6(4):564-73. PubMed ID: 4628899
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mycobacterial adjuvant and its carrier.
    Hiu IJ
    Experientia; 1975 Aug; 31(8):983-5. PubMed ID: 125657
    [No Abstract]   [Full Text] [Related]  

  • 53. Purification and characterization of two protein antigens from the heterogeneous BCG85 complex in Mycobacterium bovis BCG.
    Wiker HG; Harboe M; Lea TE
    Int Arch Allergy Appl Immunol; 1986; 81(4):298-306. PubMed ID: 3536755
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Antituberculous vaccination with freeze dried BCG vaccine. I. Properties of the dry BCG vaccine].
    KURYLOWICZ W
    Gruzlica (1926); 1955 Jan; 23(1):1-11. PubMed ID: 13251577
    [No Abstract]   [Full Text] [Related]  

  • 55. [Toxicological and pharmacological checking of freeze-dried B.C.G. vaccine for intradermal use].
    Triau R; Joubert L; Valette L; Mynard MC
    Rev Immunol Ther Antimicrob; 1967; 31(1):61-74. PubMed ID: 4860510
    [No Abstract]   [Full Text] [Related]  

  • 56. Comparison of freeze-dried daughter strains of BCG by aerogenic immunization and virulent challenge.
    Cohn ML; Davis CL; Middlebrook G
    Tubercle; 1966 Sep; 47(3):263-8. PubMed ID: 5339424
    [No Abstract]   [Full Text] [Related]  

  • 57. Preparation and properties of a freeze-dried B.C.G. vaccine of increased stability.
    UNGAR J; MUGGLETON PW; DUDLEY JA; GRIFFITHS MI
    Br Med J; 1962 Oct; 2(5312):1086-9. PubMed ID: 13995378
    [No Abstract]   [Full Text] [Related]  

  • 58. [Effects of 37 degrees centigrade temperature for 7 days on lyophilized BCG vaccine].
    LEBLOIS C
    Rev Immunol Ther Antimicrob; 1955; 19(3):152-6. PubMed ID: 13311073
    [No Abstract]   [Full Text] [Related]  

  • 59. Evaluation of the polarographic technique for assay of the viability of freeze-dried BCG vaccine: I. The polarographic technique.
    Malucelli MI; Niero R; Lucchiari PH; Bacila M
    Vaccine; 1995 Feb; 13(3):268-72. PubMed ID: 7631512
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Freeze-drying experiments with Swedish BCG vaccine.
    HESSLEBERG I; ENELL H; SIEVERS O
    Acta Pathol Microbiol Scand; 1958; 43(2):162-70. PubMed ID: 13544934
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.